Vanguard Investments Australia
NEO icon

Vanguard Investments Australia’s NeoGenomics NEO Stock Holding History

Vanguard Investments Australia’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483K Hold
33,108
– – ﹤0.01% 1676
2026
Q1 		$246K Buy
+33,108
New +$348K ﹤0.01% 1944

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Investments Australia's NEO Position: Q2 2026 in Review

Vanguard Investments Australia held its NeoGenomics (NEO) position steady in Q2 2026 at 33,108 shares worth $483K. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

Vanguard Investments Australia first reported a position in NEO in Q1 2026 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Vanguard Investments Australia held 33,108 shares of NeoGenomics worth $483K as of Q2 2026.
  • Vanguard Investments Australia left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1676 holding.
  • Vanguard Investments Australia first reported a position in NeoGenomics in Q1 2026 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.